NYC Law Firm Set to Receive LRF Award at 2017 North American Educational Forum on Lymphoma in Brooklyn
New York, NY (October 20, 2017) –The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services – will present the 2017 Hope Award to the New York City law firm Golenbock Eiseman Assor Bell & Peskoe LLP. The firm will be honored during the opening ceremony of the LRF North American Educational Forum on Lymphoma, held from October 20-22, 2017 at the New York Marriott at the Brooklyn Bridge.
Given in recognition of those individuals who have worked diligently toward the Foundation’s mission of eradicating lymphoma and serving those impacted by this blood cancer, the 2017 Hope Award will be presented to Golenbock in appreciation of the firm’s extensive pro bono counsel to the Lymphoma Research Foundation. Golenbock Eiseman Assor Bell & Peskoe LLP has assisted LRF with legal work since 2014, assisting the with a range of matters critical to the proper operation of any non-profit origination.
“Lymphoma touches more than one million people in the United States,” said Meghan Gutierrez, LRF Chief Executive Officer. “Jeff Golenbock and his colleagues are important partners in advancing our mission to eradicate lymphoma and serve those touched by this disease, and we commend them for all they have done to provide hope to those living with blood cancer.”
The Hope Award will be presented during a special welcome reception on Friday, October 20, 2017. For more information or to register for the Lymphoma Research Foundation’s North American Educational Forum on Lymphoma, visit lymphoma.org/EdForum.
About the Lymphoma Research Foundation
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded nearly $60 million in lymphoma-specific research.
For additional information on LRF’s research, education and services, visit lymphoma.org.